
News|Videos|October 23, 2023
Prostate Cancer Imaging: PSMA Agents and Radiotracer Options
Author(s)David Albala, MD
Insight into advancements in prostate cancer imaging using PSMA agents like gallium and F-18, their unique characteristics, and the considerations in choosing the right radiotracer for accurate detection.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Active surveillance use for low-risk prostate cancer reaches 93% in VA System
2
FDA receives NDA submission for UGN-103 in recurrent LG-IR-NMIBC
3
Focal therapy for prostate cancer frequently used outside guideline-supported groups
4
HoLEP learning curve and strategies for successful adoption, with Daniel S. Kellner, MD
5












